46,193 Shares in LifeStance Health Group, Inc. (NASDAQ:LFST) Purchased by AlphaQuest LLC

AlphaQuest LLC purchased a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 46,193 shares of the company's stock, valued at approximately $340,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Blue Trust Inc. increased its stake in LifeStance Health Group by 124.4% in the fourth quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after purchasing an additional 2,122 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in LifeStance Health Group by 31.4% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 24,105 shares of the company's stock valued at $169,000 after buying an additional 5,767 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in LifeStance Health Group by 10.5% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company's stock worth $572,000 after buying an additional 7,798 shares during the period. Rhumbline Advisers boosted its holdings in LifeStance Health Group by 4.5% in the fourth quarter. Rhumbline Advisers now owns 195,581 shares of the company's stock worth $1,441,000 after acquiring an additional 8,487 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in LifeStance Health Group by 0.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,113,499 shares of the company's stock worth $8,206,000 after acquiring an additional 9,046 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company's stock.

Remove Ads

LifeStance Health Group Stock Down 2.2 %

NASDAQ LFST traded down $0.15 on Tuesday, reaching $6.74. The company had a trading volume of 2,300,220 shares, compared to its average volume of 1,490,058. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The company's fifty day moving average is $7.79 and its 200 day moving average is $7.35. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $8.61. The stock has a market capitalization of $2.59 billion, a P/E ratio of -25.92 and a beta of 1.27.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on LFST. The Goldman Sachs Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 target price on the stock in a research report on Monday, December 16th. William Blair restated an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, LifeStance Health Group presently has a consensus rating of "Hold" and an average target price of $8.63.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.